112 results
S-8
ANNX
Annexon, Inc.
27 Sep 24
Registration of securities for employees
8:01am
previously approved by the Registrant’s Board of Directors on September 18, 2024.
Estimated solely for the purpose of calculating the registration fee
S-8
ANNX
Annexon, Inc.
27 Sep 24
Registration of securities for employees
8:01am
with the U.S. Securities and Exchange Commission (the “Commission”) for the purpose of registering an additional number of securities of the same … , including any amendment or report filed for the purpose of updating such description, including Exhibit 4.3 to the Registrant’s Annual Report
8-K
EX-1.1
ANNX
Annexon, Inc.
7 Jun 24
Annexon Announces Pricing of $125 Million Underwritten Public Offering
4:42pm
suspending the effectiveness of the Registration Statement has been issued by the Commission, and no proceeding for that purpose or pursuant to Section 8A … , threatening of any proceeding for that purpose or pursuant to Section 8A of the Securities Act; (vi) of the occurrence of any event or development within
8-K
EX-4.1
qv8kl gfxw
7 Jun 24
Annexon Announces Pricing of $125 Million Underwritten Public Offering
4:42pm
424B5
vm8a3w0o4q53p9j7t947
6 Jun 24
Prospectus supplement for primary offering
9:57pm
424B5
byf8ccs nhslnzn
4 Jun 24
Prospectus supplement for primary offering
5:21pm
8-K
EX-99.2
bx63mz
4 Jun 24
Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blocking Antibody ANX005 in Guillain-Barré Syndrome
7:05am
424B5
tkh86n1dpxvh459c
5 Apr 24
Prospectus supplement for primary offering
4:07pm
S-8
7dqfpetvkqcs
26 Mar 24
Registration of securities for employees
5:01pm
S-8
27ham
26 Mar 24
Registration of securities for employees
5:01pm